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Abstract. The substantial influx of foreign-born persons including immigrant population into the community 
becomes one of the postulated reasons to be elucidated relating to this so-called “a disease without border” 
in Malaysia. A total of 425 TB patients, including Malaysians and foreigners, were treated at the Institute of 
Respiratory Medicine from May to December 2003.  TB was found relatively more often in foreign laborers 
and Malaysians with nonspecific occupations. Tuberculin skin test (TST) was used to screen for latent TB 
infection and a higher positive rate of TST was found in foreign compared to local patients. Chest X-ray 
findings showed a higher rate of abnormalities consistent with PTB, found in the majority of both groups. 
Lymph node biopsy and sputum culture were used significantly to detect the presence of M. tuberculosis 
and confirm the diagnosis of TB. EHRZ+B6 was significantly the most commonly used anti-tubercular drug 
regimen, found in both local and foreign patients. Foreign patients were more significantly associated with 
non-compliance to anti-tubercular therapy.  Hepatitis was one of the most common adverse drug reactions 
found in local patients. The presence of a greater number of illegal migrants, who are highly mobile within 
the country as well as across borders, and who do not undergo any health screening, further complicates 
the national tuberculosis control program in the future.
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INTRODUCTION
 Tuberculosis (TB) is one of the world’s 
most important infectious causes of morbidity 
and mortality among adults. Between 8 to 
9 million people develop the disease, and 
approximately 2 million die from TB each year 
(Pai et al, 2006).  TB is mainly concentrated 
in developing countries, and global control 
efforts have been hampered by the limitations 
of diagnostic, prophylactic, and therapeutic 
tools (Freire, 2006). This resurgent disease has 
become a significant worldwide public health 
problem and is largely related to immigration 
from countries with a high prevalence of TB; 
infection with HIV; social problems, such as 
poverty, homelessness, and drug abuse; and 
dismantling of TB services (Raviglione and 
O’Brien, 2005). In Malaysia, about 10% of TB 
notified cases have been discovered among the 
immigrant population, particularly those from 
high TB burden neighboring countries (Iyawoo, 
2004). Immigrants contributed more than 24% 
of the newly detected TB cases in Sabah, East 
Malaysia (Dony et al, 2004). The substantial 
influx of foreign-born persons including the 
immigrant population into the community has 
become one of the reasons why TB could be 
called “a disease without borders” in Malaysia. 
We conducted this study in order to compare the 
course of tuberculosis in terms of epidemiology, 
clinical manifestations, investigation, and 
treatment outcomes between Malaysian (local) 
and foreign-born patients. This study certainly 
provided a picture of the current situation of TB 
in these patients, particularly in the latter group. 
It could also be useful for the host country to 
establish preventive measures and regional 
collaboration to curb the future incidence of TB 
among foreign-born persons.
MATERIALS AND METHODS
 A total of 425 patients including 297 (69.9%) 
Malaysian (local) and 128 (30.1%) foreigners 
who were confirmed as non-HIV infected patients 
and registered for tuberculosis treatment at the 
Institute of Respiratory Medicine (IRM) from 
May to December, 2003 were included in this 
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study. This institute is a tertiary level national 
referral center for respiratory diseases, situated 
in Kuala Lumpur, Malaysia. Any person with a 
respiratory problem can attend this center without 
a physician’s referral.  The majority of notified 
TB cases in Kuala Lumpur each year are treated 
there. The data was retrospectively reviewed from 
each patient’s medical record. Socio-demographic 
profiles, clinical presentations, investigation 
results, treatment, patient compliance with 
therapy, and outcomes of therapy response 
were included in a standardized data collection 
sheet. A country like Malaysia still attracts more 
foreigners in each year to come in for different 
purposes, such as working and/or studying. 
These foreign patients were mainly from its 
neighboring countries:  Indonesia (89), Myanmar 
(16), Philippines (3), Thailand (1), and Vietnam 
(2). Others were from Nepal (5), Bangladesh 
(4), India (3), Pakistan (2), and 1 each from 
Africa and Japan. Of these, 21 (17 Indonesian 
and 4 Burmese) patients resided in this country 
more than 10 years, while the remaining (107) 
had less than 10 years (range of 1 month to 9 
years) residency. The group was comprised of 
job seekers or laborers (78; 63%), non-laborers 
(30; 24.2%), and others, such as housewives 
and students (16; 13%). The case definitions of 
tuberculosis were obtained from the World Health 
Organization (WHO, 2002).
Statistical analysis
 The data were analyzed employing the 
statistical software, SPSS version 11 (SPSS Inc, 
Chicago, Ill, USA). The data with quantitative 
variables were described as mean and range, 
while qualitative variables were described as 
frequency and percentage.  Statistical analysis 
was estimated using chi-square test where 
appropriate. A p-value of <0.05 was regarded as 
statistically significant. 
RESULTS
 Table 1 shows the demographic profiles of 
425 TB patients comprising Malaysian (297, 
70%) and foreigners (128, 30%) who attended 
the Institute of Respiratory Medicine (IRM) from 
May to December 2003. Overall, the incidence of 
tuberculosis in this study was high in both local 
(270; 90.9%) and foreign (119; 93%) patients. The 
age range was found to be older in local than in 
foreign patients. Both groups had the significantly 
highest percentage in the age group of 21-40 
years, and the occurrence of TB slowly declined 
in the locals when compared to that of foreign 
patients, which decreased markedly over the 
years (p = 0.000). TB occurred more commonly 
in married-and-male than unmarried-and-female 
patients, in both groups. However, no statistical 
difference was found between both groups (p 
>0.05). TB was found relatively more often in 
foreign laborers and Malaysian with nonspecific 
occupations (p = 0.000). A significant one-third of 
these patients, including 121 (40.7%) Malaysian 
and 12 (9.4%) foreigners, were given BCG 
vaccination (p = 0.000). Smoking was the most 
common predisposing factor for the occurrence of 
TB, found in both groups (p >0.05). Both groups 
(39, 13.1% Malaysian vs 13, 10.2% foreigner) 
showed similar results with a previous history of 
contacting TB (p >0.05). Intravenous drug use was 
more significantly found in national (49, 16.8%) 
than foreign (3, 2.3%) patients (p = 0.000).
 Clinical manifestations and investigation of 
the 425 TB paients are presented in Table 2. A 
significant majority of patients in both groups 
had fever (Malaysian, 55% vs foreigner, 67.2%), 
loss of appetite (Malaysian, 55.2% vs foreigner, 
67.2%), weight (Malaysian, 56.2% vs foreigner, 
72.7%), and hemoptysis (Malaysian, 16.8% vs 
foreigner, 33.6%) (p < 0.05). Cough (Malaysian, 
73.1% vs foreigner, 79%) and sputum (Malaysian, 
54% vs foreigner, 53.1%) were also more 
common in these patients. However, no statistical 
difference was found between these two groups 
(p > 0.05).  Lymphadenopathy occurred more 
commonly in local (59, 20%) than foreign (17, 
13.3%) patients, and the cervical lymph nodes 
were the most common location found in both 
groups (p >0.05). Tuberculin skin test (TST) or 
Mantoux test was used to screen for latent TB 
infection, and an optimum cut-off point ≥ 10 mm 
(p = 0.07) when compared to ≥ 5 (p = 0.112) or 
≥15 (p = 0.407) mm was considered to be a better 
correlation. A higher positive rate of TST was 
found in foreign (32, 25%) than local (56, 19%) 
patients.  A similarly positive ESR was shown in 
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Table 1
Demographic profile of 425 TB patients attended at the Institute of Respiratory Medicine (IRM) 
during May-December 2003.
 Variable No of patients (%) p-value
  Malaysian (297) Foreigner (128) 
  Aged range  = 15 to 93 with a median of 39 years 
  Aged range = 15-93 years Aged range = 18-75 years 
  Median = 44 years Median = 30 years 
Age group     0.000
 ≤ 20   11 (3.7)     8  6.3) 
 21-40 118 (39.7)   92 (72) 
 41-60   98 (33)   23 (18) 
 ≥ 61   70 (23.6)     5 (4) 
Sex     0.291
 Male 208 (70)   83 (64.8) 
 Female   89 (30)   45 (35.2) 
Marital status     0.046
 Single 102 (34.3)   57 (44.5) 
 Married 195 (65.7)   71 (55.5) 
Present address     0.018
 Kuala Lumpur 158 (53.2)   84 (65.6) 
 Outsider 139 (46.8)   44 (34.4) 
Occupation     0.000
 Laborer   46 (15.5)   78 (61.2) 
 Non-laborer   47 (15.8)   30 (23.4) 
 Othersa 204 (68.7)   20 (15.6) 
BCG vaccination status     0.000
 Yes 121 (40.7)   12 (9.4) 
 No or unknown 176 (59.3) 116 (90.6) 
Risk factors     0.427
Yes  114 (39.4)  40 (31.3) 
 Smoking   92 (31)  34 (26.6) 
 Alcohol consumption     2 (0.7)    0 
 Smoking and drinking   20 (6.7)    6 (4.7) 
No 183 (61.6)   88 (68.8) 
Case category     0.193
New case 270 (90.9) 119 (93) 
Old case (previous TB history)   27 (9.1)     9 (7) 
 With completed treatment   10 (3.4)     1 (0.8) 
 With uncompleted treatment   17 (5.7)     8 (6.3) 
History of contact with TB     0.391
 Yes    39 (13.1)     13 (10.2) 
 No 258 (86.9)   115 (89.8) 
Intravenous drug use (IDU)     0.000
 Yes   49 (16.8)     3 (2.3) 
 No/unknown 
  248 (83.2) 125 (97.7) 
aOthers included housewife, students retired persons
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the majority of local (269, 90.6%) and foreign 
(118, 92.2%) patients (p >0.05). Interestingly, 
HCV infection rates were comparatively higher 
in local (42, 14%) than foreign (3, 2.3%) patients 
(p = 0.001). Chest X-ray findings showed a higher 
rate of abnormalities consistent with PTB found 
in both groups (p = 0.014). Lymph node biopsy 
(p = 0.004) and sputum culture (p = 0.003) were 
used significantly to detect the presence of M. 
tuberculosis and confirm the diagnosis of TB.
 Table 3 shows the diagnosis and treatment 
outcomes of the 425 TB patients. Pulmonary (lung) 
was the most common location (Malaysian, 58.6% 
vs foreigner, 75%), followed by extrapulmonary 
(Malaysian, 27.6% vs foreigner, 16.4%), and 
pulmonary with disseminated TB (Malaysian, 
13.8% vs foreigner, 8.6%), which was significant 
in both groups (p = 0.005). Lymph node and 
lung with lymph node were the most common 
forms of extrapulmonary, and pulmonary with 
disseminated TB, respectively. EHRZ+B6 was 
significantly the most commonly used anti-
tubercular drug regimen, found in both local 
(192, 64.7%) and foreign (116, 90.6%) patients 
(p = 0.000). A higher cure rate of ≥6 months 
anti-tubercular drug regimen was significantly 
found in both groups (Malaysian, 25.6% vs 
foreigner, 29%), compared to other regimens 
(p=0.004). A longer duration (≥9 and 12 months) 
of treatment was more commonly found in local 
than foreign patients. Non-compliance to therapy 
was more significantly found among foreign 
(29%) than among local (19%) patients. There 
were 22 patients (20 Malaysian vs 2 foreigner) 
who developed adverse drug reactions. Of these, 
there was hepatitis (4 patients), visual impairment 
(5), liver impairment (6), skin reaction-rash 
(4), thrombocytopenia (2), and hearing deficit 
(1) found in Malaysian patients; while visual 
impairment (1) and skin reaction-rash (1) were 
among the adverse reactions recorded in foreign 
patients. Only 1 patient was recorded having 
antituberculous drug (rifampicin) resistance. 
Overall, no MDR-TB or death was reported in 
these patients during the time of this study.
DISCUSSION
 From our study, the incidence of TB was 
comparatively higher in foreign patients in this 
country. This is not surprising as this has also 
become increasingly apparent in many countries 
such as Australia, Canada, the Netherlands, and 
the United State (Rieder et al, 1994; Raviglione 
et al 1995; Wells et al, 1999). Tuberculosis was 
significantly more common in older locals. This 
could be explained because the majority of foreign 
patients stay temporarily in this country for the 
improved income or standard of living, as clearly 
shown in this study. The reactivation of primary 
infection due to lowered body immunity with age 
or other co-diseases such as diabetes mellitus or 
disease requiring the use of steroids would be 
alternative explanations for the local patients 
(Venugopalan, 2004). Moreover, a higher rate of 
TB cases was found in men than women in both 
groups. This finding is supported by most of the 
previous studies worldwide and this could also 
be explained by the higher mobility of the male 
group due to work requirements (Venugopalan, 
2004; WHO, 2004a). Nevertheless, women 
progress from infection to active TB faster than 
men do, but the reported incidence of pulmonary 
TB among women is nearly always lower than 
for men (WHO, 2004b).  
 Approximately, one-third of these patients 
(more in local than foreign patients) were given 
BCG vaccination. This suggests that BCG 
vaccination is still compulsory, and public 
health awareness should be more consistently 
implemented to promote the national vaccination 
program in any given population, particularly 
in limited resource settings. However, the 
development of a vaccine better than BCG is also 
encouraged for the developing countries where the 
risk of TB infection remains high (Shimao, 2005). 
We observed that IDUs was more likely found 
among local TB patients. This supports with the 
fact that IDUs is not only the most common route 
of HIV transmission, particularly in the  younger 
age group in Malaysia, but also a significant 
risk factor in contributing to the transmission 
of TB/HIV co-infection as reported worldwide. 
Therefore, the higher authorities should take 
more serious steps to tackle this problem, since 
these two diseases are very contagious and pose 
a major public health concern in this region.
 Looking at the clinical diagnosis, our findings 
Vol 38  (suppl 1)  2007 235
tuberculoSiS in MalaySia
Table 2
Clinical manifestations and investigation results of 425 TB patients.
 Variable No of patients (%) p-value
  Malaysian (297) Foreigner (128) 
Clinical manifestations   
 Fever 163 (55)  86 (67.2) 0.018
 Loss of appetite 164 (55.2)  86 (67.2) 0.021
 Loss of weight 167 (56.2)  93 (72.7) 0.001
 Cough 217 (73.1) 101 (79) 0.203
 Sputum 160 (54)  68 (53.1) 0.887
 Hemoptysis   50 (16.8)  43 (33.6) 0.000
 Dysnea   39 (13.1)  21 (16.4) 0.374
 Others   63 (21.2)  23 (18) 
 Lymphadenopathy   59 (20)  17 (13.3) 0.104
Site of lymph node involvement     0.554
 Cervical   42 (14.1)  10 (7.8) 
 Other   17 (5.7)    7 (5.5) 
Investigation results   
Mantoux test     0.07
 Positive ≥ 10 mm   56 (19)  32 (25) 
 Negative    41 (13.8)    9 (7) 
 Unknown 200 (67.3)  87 (68) 
ESR     0.381
 Normal    10 (3.4)    6 (4.7) 
 Positive ≥ 10 mm/1st hour   269 (90.6) 118 (92.2) 
 Unknown   18 (6.1)    4 (3.1) 
HBV infection     0.753
 Positive   14 (4.7)     4 (3.1) 
 Negative 102 (34.3)   44 (34.3) 
 Unknown 181 (61)   80 (62.5) 
HCV infection     0.001
 Positive   42 (14)     3 (2.3) 
 Negative   71 (24)   35 (27.3) 
 Unknown 184 (62)   90 (70.3) 
CXR finding      0.014
 Normal   47 (15.8)     9 (7) 
 Positive for PTB 176 (59.3)   95 (74.2) 
 Positive for PTB and 
  disseminated    43 (14.5)   11 (8.6) 
 Positive for ETB   31 (10.4)   13 (10.2) 
Lymph node biopsy     0.004
 Yes   46 (15.5)     7 (5.5) 
 No/Unknown 251 (84.5) 121 (54.5) 
Sputum smear     0.173
 Positive 102 (34.3)   56 (43.8) 
 Negative 191 (64.3)   70 (54.7) 
 Unknown    4 (1.4)     2 (1.6) 
Sputum culture for MTB     0.003
 Positive  125 (42.1)   77 (60.2) 
 Negative 156 (52.5)   47 (36.7) 
 Unknown 16 (5.4)    4 (3.1) 
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Table 3
Diagnosis and treatment outcomes of 425 TB patients.
 Variable No of patients (%) p-value
  Malaysian (297) Foreigner (128) 
Site of organ involvement     0.246
 Lung 174 (58.6)  96 (75) 
 Lung and LN   25 (8.4)   9 (7) 
 Lung and other (pleura, spine,    16 (5.4)   2 (1.6) 
  larynx and miliary)   
 Lymph node (LN) and/or others   39 (13.1)   9 (7) 
 Miliary and/or others   20 (6.7)   5 (3.8) 
Other (pleura, bone, GIT, GUT, etc)  23 (7.7)   7 (5.5) 
Type of tuberculosis     0.005
 Pulmonary 174 (58.6)  96 (75) 
 Pulmonary and extrapulmonary   41 (13.8)  11 (8.6) 
 Extrapulmonary   82 (27.6)  21 (16.4) 
Anti-tubercular drugs regimen     0.000
 EHRZ+B6 192 (64.7) 116 (90.6) 
 SHRZ+B6   85 (28.6)    9 (7) 
 Other   20 (6.7)    3 (2.3) 
Treatment outcome     0.004
 ≥ 6 months   76 (25.6)  37 (29) 
 ≥ 9 months   69 (23.2)  12 (9.4) 
	 ≥ 12 months   13 (4.4)    1 (0.8) 
 On going treatment   
 < 6 months   55 (18.5)  30 (23.4) 
 ≥ 6 months   28 (9.4)  11 (8.6) 
 Loss to follow-up   56 (19)  37 (29) 
 Transfer out   15 (5.1)  10 (7.8)
showed that both groups displayed similar 
clinical features, which also depend upon organs 
involvement relating to TB disease. Pulmonary 
TB patients were significantly found as having 
clinical manifestations such as fever, loss of 
appetite and weight, and hemoptysis, which is in 
agreement with an earlier study (Chowell et al, 
2005). This suggests that TB should be considered 
one of differential diagnosis for patients with 
persistent fever or unresolved in management of 
other diseases in these cases. TST was used as one 
of the routine investigations for the diagnosis of 
latent TB infection and showed a higher positive 
rate among foreign compared with local patients. 
A TST reading of 10 mm had a higher sensitivity 
than 15 mm (Tan et al, 2002) as a cut-off point in 
TB diagnosis (Loh et al, 2005), as also shown in 
this study. However, interpretation of TST might 
be difficult, particularly in the Malaysian settings 
of multi-ethnicity and high BCG coverage (Loh 
et al, 2005). This test is of limited value in the 
diagnosis of active tuberculosis because of 
its low sensitivity and specificity (Raviglione 
and O’Brien, 2005); it often gives false results 
(Kunst, 2006) and is therefore not applicable for 
the diagnosis of latent TB infection.  Interferon-
gamma assays are newly available tests to detect 
latent TB infection and might allow targeting 
chemoprophylaxis to reduce the burden of active 
TB. However, this assay is currently not routinely 
used (Kunst, 2006). Radiographic images from 
chest X-ray finding are one of the important 
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investigations used, particularly in diagnosing 
PTB. Pulmonary tuberculosis is unlikely in 
the absence of any radiographic abnormality 
(Raviglione and O’Brien, 2005). At the same 
time, sputum examination, particularly from 
sputum culture, is used not only as a significantly 
confirmatory method in detecting the presence 
of M. tuberculosis but also for screening of both 
primary drug susceptibility and resistance, which 
could prevent further escalation of the existing 
multi-drug resistant TB.
 Concerning TB treatment and its outcome, 
a higher overall cure rate was found in local 
compared with foreign patients. Compliance is 
one of the potential factors to increase the cure 
rate in TB patients and the type of treatment, 
gender, occupation, history of contacting TB, 
perception in health status, attitude, knowledge, 
and social support were found to be significantly 
contributing factors (Lertmaharit et al, 2005). 
With the presently available anti-tuberculosis 
drugs, a six months regimen is comparatively 
effective in treating PTB, found in both groups 
of patients. In addition, the regimen of more 
than 9 months duration was given more in PTB-
disseminated and ETB patients when compared 
to only PTB cases. This therefore indicates 
that compliance and sites of TB involvement 
determine the duration of treatment regimen used 
in these patients. A revolutionary concept for TB 
drug development and leveraging the potential of 
the existing drugs pipeline (Freire, 2006) is the 
future trend for the treatment of TB. In addition, 
a potent new drug, which has no cross-resistance 
with existing TB drugs, is targeted to make 
another great contribution to global TB control 
(Shimao, 2005).  
 Non-compliance to therapy was more likely 
found in foreign compared with local patients. A 
significant reason in this finding was occupation, 
with a majority of these patients being laborers 
(24/37) who might not understand the disease, 
particularly long-term treatment that requires 
strict cooperation throughout the course of 
treatment. To circumvent this problem, their 
employers should take the initiative to provide 
job security and especially medical services 
to prevent the spread of tuberculosis infection 
within their respective communities.  
 Adverse drug reactions were found at a higher 
rate among local than among foreign patients. 
Hepatitis was one of the most common side 
effects in patients with the age of more than 45 
years (3/4), and there was evidence of relapse 
TB found in one of these patients. Supporting 
this finding, one study showed that the risk of 
hepatitis increased from 2.6% to 4.1% as age 
exceeded 49 years, and, if patients at risk of both 
hepatitis and relapse were to receive standard 
treatment, daily dosing was preferable (Chang 
et al, 2006). This suggests that observation of 
these side effects should be consistently taken 
into serious consideration, and communication 
between medical personnel and patients would 
be mandatory to prevent future drug resistance. 
So far, only one local patient developed drug 
resistance, while there was no report among 
foreign patients. However, one study showed 
that the risk of drug resistance was the highest 
for younger TB patients and among foreign-
born patients from Vietnam and the Philippines 
(Moniruzzaman et al, 2006). This assists clinicians 
in prescribing and tailoring more appropriate 
anti-tuberculosis regimens for immigrants 
(Moniruzzaman et al, 2006).  However, there 
was no registered case of multi-drug resistant 
tuberculosis (MDR-TB), in either local and 
foreign (Nissapatorn et al, 2005) patients found in 
this study. MDR-TB is not yet a serious problem 
in Malaysia as evidenced by the Drug Resistance 
Surveillance completed in 1996/1997 with WHO 
collaboration, and MDR-TB prevalence was 
found to be 0.1% in Malaysia (Iyawoo, 2004). 
MDR-TB, however, is the subject of great interest 
and has consistently gained attention worldwide. 
The monthly monitoring of sputum culture for 
AFB in the initial 6 months of treatment helps 
greatly to predict treatment outcomes (Yew 
et al, 2000). Moreover, one study suggested 
that regimens with at least four sensitive drugs 
are mandatory for the successful treatment of 
MDR-TB and fluoroquinolones are needed in 
the majority of cases to ensure the success of 
the four-drug regimen, because of frequent drug 
resistance or toxicity to other anti-tuberculosis 
drugs (Shigetoh, 2001). Overall, most patients 
with multi-drug-resistant tuberculosis can be 
cured with the use of appropriate, intensive 
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treatment regimens (Tahaoglu et al, 2001), and 
drug selection must rely on treatment history, 
results of susceptibility testing and an evaluation 
of the patient’s adherence (API Consensus Expert 
Committee, 2006).
 In conclusion, tuberculosis is still highly 
prevalent and found in a given population in 
Malaysia. Age group certainly contributes to the 
occurrence of TB. BCG vaccination and TST 
are still compulsory in developing countries 
where the incidence of TB remains high. Clinical 
presentations have shown similarity between 
both groups and depended upon the sites of 
TB involvement. A higher cure rate of anti-
tuberculosis therapy of ≥6-month duration was 
found in both groups of TB patients. Medical 
examinations should be a strictly mandatory 
prerequisite in order to obtain a work permit 
among foreigners before they enter the country. 
Moreover, the presence of a substantial number of 
illegal migrants, who are highly mobile within the 
country as well as across borders, and who do not 
undergo any health screening, further complicates 
the national tuberculosis control program in the 
future.  
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